WebTENAYA THERAPEUTICS, INC. CORPORATE GOVERNANCE GUIDELINES (Adopted on June 17, 2024 and effective as of the Company’s initial public offering) A. POLICY OVERVIEW …
Did you know?
WebThe board of directors at Tenaya Therapeutics has experience in the medical and business industries. Some of their previous experiences include working as the Chief Business Officer at REGENXBIO Inc., being a committee member at the Massachusetts Institute of Technology, and chairing the Reimbursement Committee at Alliance for Regenerative … Web22 Dec 2024 · December 22, 2024 - 4:05 pm. SOUTH SAN FRANCISCO, Calif. Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced the appointments of Karah Parschauer, J.D., to its Board of Directors …
Web7 Dec 2024 · SOUTH SAN FRANCISCO, Calif., Dec. 07, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a … Web22 Nov 2024 · SOUTH SAN FRANCISCO, Calif.-- ( BUSINESS WIRE )--Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address...
Web22 Nov 2024 · SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Tenaya Therapeutics (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced changes to its Board of Directors including the addition of June Lee, M.D., and the … WebThe board of directors at Tenaya Therapeutics has experience in the medical and business industries. Some of their previous experiences include working as the Chief Business …
Web8 Dec 2024 · SOUTH SAN FRANCISCO, Calif., Dec. 07, 2024 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced the appointment of Amy Burroughs to its Board …
WebPublic company experience as a Chief Executive Officer, Corporate Board member and Chief Financial Officer with a demonstrated history of working in the biotechnology industry. syam cylinder connectionWeb22 Dec 2024 · “Both Karah and Joanna are strong leaders who bring highly relevant strategic and operational experiences to Tenaya, and who also add to the diversity of our … syam ancrageWeb7 Dec 2024 · Tenaya Therapeutics Appoints Amy Burroughs to Board of Directors. SOUTH SAN FRANCISCO, Calif., Dec. 07, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. … text to speech weiblichWebBen Boyer is a Managing Director of Tenaya Capital, and he has been a member of the Tenaya investment team since 2000. Previously, Ben was a member of Lehman Brothers' Technology Investment Banking group, where he was responsible for corporate finance and strategic advisory assignments. Ben holds an M.B.A. from Stanford Graduate School. syamil dodo teacher chill coverWeb22 Nov 2024 · SOUTH SAN FRANCISCO, Calif. -- (BUSINESS WIRE)--Nov. 22, 2024-- Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, … syam fireplaceWebJeffrey T. Walsh Independent Director: Tenaya Therapeutics, Inc., Tevard Biosciences, Inc. Jin-Long Chen Independent Director: NGM Biopharmaceuticals, Inc., Tenaya … text to speech website onlineWeb7 Dec 2024 · SOUTH SAN FRANCISCO, Calif., Dec. 07, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced the appointment of Amy Burroughs to its Board … text to speech western